Asymptomatic Carotid Surgery Trial (ACST) Asymptomatic Carotid Surgery Trial (ACST)
Follow-Up Continues For 10 Year Results
We thank all our collaborators and their teams for their continuing support of this very important study. Your hard work is much appreciated. Keep up the good work!
We aim to work on the data analysis from late summer through autumn 2007 and plan to publish the 10 year results in early 2008.
However there is still time to send us your final follow-ups! There are some centres for whom we still require a 2006/2007 follow-up in order to complete the data collection. Please return these to us NOW .
Even if patients are difficult to find, please try one more time by contacting the patient relatives, family doctor or national database or medical registries
______________________________
ACST-2
If a patient needs treatment for asymptomatic carotid stenosis, there may be substantial uncertainty shared by the doctor and patient about whether to opt for carotid endarterectomy (CEA) or carotid artery stenting (CAS). ACST-2 seeks to randomise such individuals between CEA and CAS to compare both the immediate hazards of the two procedures within the first few weeks and the long-term stroke rates over the next 5 to 10 years.
ACST-2 is a large, simple, randomised trial of CEA versus CAS for stroke prevention and is designed to maximise recruitment by minimising the workload per patient so that it can be integrated easily in routine health care. Minimal data are required at randomisation and at the 1-month follow-up after the patient has undergone the procedure (CEA or CAS), after which annual follow-up will be organised by the ACST-2 coordinating office. The Randomisation Notepad and the 1-month follow-up form are the ONLY forms that routinely need to be completed by the doctor.
If you are interested in joining ACST-2 please email your contact details to acst@sgul.ac.uk
______________________________________________
Meeting and Conferences:
Come and see us:
This year we have a stand at:
ACST presentations are being at:
We also have stands next year at:
We hope to see you there!
